Growth Metrics

Fulgent Genetics (FLGT) Change in Cash (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Change in Cash for 11 consecutive years, with -$67.4 million as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 2227.4% to -$67.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.0 million through Dec 2025, up 88.27% year-over-year, with the annual reading at -$5.0 million for FY2025, 88.27% up from the prior year.
  • Change in Cash hit -$67.4 million in Q4 2025 for Fulgent Genetics, down from $29.8 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $188.2 million in Q1 2022 to a low of -$214.3 million in Q2 2022.
  • Historically, Change in Cash has averaged -$1.9 million across 5 years, with a median of $3.8 million in 2024.
  • Biggest five-year swings in Change in Cash: surged 2504.62% in 2021 and later plummeted 2227.4% in 2025.
  • Year by year, Change in Cash stood at -$50.0 million in 2021, then crashed by 78.59% to -$89.3 million in 2022, then surged by 115.01% to $13.4 million in 2023, then crashed by 121.63% to -$2.9 million in 2024, then tumbled by 2227.4% to -$67.4 million in 2025.
  • Business Quant data shows Change in Cash for FLGT at -$67.4 million in Q4 2025, $29.8 million in Q3 2025, and $20.6 million in Q2 2025.